Dr. Beaston has been a Medical Officer at the Food and Drug Administration for more than 20 years. She began in the Center for Drug Evaluation and Research evaluating endocrine drug products. She then moved to the Center for Devices and Radiological Health (CDRH) where she provided clinical consultation on endocrine related devices including diagnostic, software, drug delivery and combination products. She is now in Division of Clinical Evaluation General Medicine (DCEGM)/ Office of Clinical Evaluation (OCE)/ Office of Therapeutic Products (OTP)/ Center for Biologics Evaluation and Research (CBER) where her review work includes islet cell transplantation, immune modulation in type 1 diabetes, gene therapies for inborn errors of metabolism, and xeno-transplantation. Dr. Beaston earned a B.S. in Zoology from the University of Maryland, College Park, a Ph.D. in Anatomy and Neurobiology, and an M.D. from the Medical College of Pennsylvania, Philadelphia. She completed her residency in Internal Medicine at the Medical College of Pennsylvania and was a Fellow in Diabetes, Endocrinology, and Metabolism at PennState/Hershey where she did basic research in addition to her clinical responsibilities.